Metoclopramide Nasal Spray (Gimoti) for Diabetic Gastroparesis
Date: January 11, 2021
Issue #:
1615Summary:
The FDA has approvedGimoti (Evoke), a nasal
spray formulation of the dopamine-2 (D2) receptor
antagonist metoclopramide, for relief of symptoms in
adults with acute and recurrent diabetic gastroparesis.
Metoclopramide (Reglan, and generics) has been
available for years in conventional and orally-disintegrating
tablets and in an injectable formulation.
It is the only drug that is FDA-approved for treatment
of diabetic gastroparesis.
Source: The Medical Letter - Category: Drugs & Pharmacology Authors: admin Tags: Antibacterials Azithromycin diabetic gastroparesis Domperidone Erythromycin Gimoti Metoclopramide Motilium ondansetron Promethazine Reglan Scopolamine Source Type: research
More News: Azithromycin | Diabetes | Drugs & Pharmacology | Endocrinology | Erythromycin | Gastroenterology | Metoclopramide | Promethazine | Zithromax | Zofran